| scholarly article | Q13442814 |
| P2093 | author name string | M Li | |
| T P Cripe | |||
| R L Garcea | |||
| M K Lyon | |||
| R C Rose | |||
| P A Estes | |||
| P2860 | cites work | Polymorphism in the assembly of polyomavirus capsid protein VP1 | Q24537372 |
| Crystal structures of murine polyomavirus in complex with straight-chain and branched-chain sialyloligosaccharide receptor fragments | Q27733369 | ||
| Conserved features in papillomavirus and polyomavirus capsids | Q28654303 | ||
| Structures of bovine and human papillomaviruses. Analysis by cryoelectron microscopy and three-dimensional image reconstruction | Q30447715 | ||
| In vitro assay for protein-protein interaction: carboxyl-terminal 40 residues of simian virus 40 structural protein VP3 contain a determinant for interaction with VP1. | Q33646308 | ||
| Self-assembly of purified polyomavirus capsid protein VP1. | Q34162517 | ||
| Characterization of the DNA-binding properties of the polyomavirus capsid protein VP1 | Q34778230 | ||
| Papillomavirus L1 capsids agglutinate mouse erythrocytes through a proteinaceous receptor | Q35845291 | ||
| Expression of the polyomavirus minor capsid proteins VP2 and VP3 in Escherichia coli: in vitro interactions with recombinant VP1 capsomeres | Q35852116 | ||
| Structural polypeptides of rabbit, bovine, and human papillomaviruses | Q36535294 | ||
| Interaction of human papillomavirus (HPV) type 16 capsid proteins with HPV DNA requires an intact L2 N-terminal sequence | Q36626328 | ||
| Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins | Q36639439 | ||
| Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of viruslike particles | Q36685977 | ||
| Nuclear assembly of polyomavirus capsids in insect cells expressing the major capsid protein VP1 | Q36797861 | ||
| DNA-binding activity of papillomavirus proteins | Q36887975 | ||
| Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic | Q37353496 | ||
| Characterization of a nuclear localization sequence in the polyomavirus capsid protein VP1 | Q38332754 | ||
| Stabilizing effect of divalent metal ions on virions of southern bean mosaic virus | Q39085385 | ||
| Metal-free southern bean mosaic virus crystals | Q39252667 | ||
| Identification of proteins encoded by the L1 and L2 open reading frames of human papillomavirus 1a. | Q40140413 | ||
| Serological differentiation of human papillomavirus types 11, 16 and 18 using recombinant virus-like particles | Q41019646 | ||
| Synthesis and assembly of infectious bovine papillomavirus particles in vitro | Q41563515 | ||
| Assembly of the major and the minor capsid protein of human papillomavirus type 33 into virus-like particles and tubular structures in insect cells | Q42068510 | ||
| Site-directed mutation affecting polyomavirus capsid self-assembly in vitro | Q44631743 | ||
| Human papillomavirus (HPV) type 11 recombinant virus-like particles induce the formation of neutralizing antibodies and detect HPV-specific antibodies in human sera | Q45780898 | ||
| Divalent ion-dependent reversible swelling of tomato bushy stunt virus and organization of the expanded virion | Q45792386 | ||
| Polyoma virus major capsid protein, VP1. Purification after high level expression in Escherichia coli. | Q45838099 | ||
| Structure of simian virus 40 at 3.8-A resolution | Q45861692 | ||
| Identification of the nuclear localization signal of human papillomavirus type 16 L1 protein | Q53743465 | ||
| Antibody-Mediated Neutralization of Human Papillomavirus Type 11 (HPV-11) Infection in the Nude Mouse: Detection of HPV-11 mRNAs | Q67485675 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Escherichia coli | Q25419 |
| P304 | page(s) | 2988-2995 | |
| P577 | publication date | 1997-04-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Expression of the human papillomavirus type 11 L1 capsid protein in Escherichia coli: characterization of protein domains involved in DNA binding and capsid assembly | |
| P478 | volume | 71 |
| Q40238745 | A deletion and point mutation study of the human papillomavirus type 16 major capsid gene |
| Q42784779 | A parameter estimation technique for stochastic self-assembly systems and its application to human papillomavirus self-assembly |
| Q43096878 | Analysis of modified human papillomavirus type 16 L1 capsomeres: the ability to assemble into larger particles correlates with higher immunogenicity |
| Q37242405 | Antigenic presentation of heterologous epitopes engineered into the outer surface-exposed helix 4 loop region of human papillomavirus L1 capsomeres |
| Q28743261 | Capsomer vaccines protect mice from vaginal challenge with human papillomavirus |
| Q37307576 | Cervarix: a vaccine for the prevention of HPV 16, 18-associated cervical cancer. |
| Q42072226 | Chaperone-mediated in vitro disassembly of polyoma- and papillomaviruses |
| Q73733757 | Characterization of IgA response among women with incident HPV 16 infection |
| Q33813986 | Characterization of a major neutralizing epitope on human papillomavirus type 16 L1 |
| Q36115229 | Characterization of human papillomavirus type 16 pseudovirus containing histones |
| Q36775528 | Clinical and epidemiological correlates of antibody response to human papillomaviruses (HPVs) as measured by a novel ELISA based on denatured recombinant HPV16 late (L) and early (E) antigens |
| Q39041312 | Cruising the cellular highways: How human papillomavirus travels from the surface to the nucleus |
| Q28289555 | Current Status of Human Papillomavirus Vaccines |
| Q37346447 | Design of virus-based nanomaterials for medicine, biotechnology, and energy |
| Q37735036 | Effects of siRNA-mediated suppression of HPV-11 L1 expression on the proliferation and apoptosis of vaginal epithelial cells |
| Q56967486 | Emerging human papillomavirus vaccines |
| Q42785059 | Evolutionary and structural analyses of alpha-papillomavirus capsid proteins yields novel insights into L2 structure and interaction with L1. |
| Q33298684 | Expression of HPV-11 L1 protein in transgenic Arabidopsis thaliana and Nicotiana tabacum |
| Q39973023 | Expression of human papilloma virus type 16 antigens, specific targeting as well as formation of virus-like particles by HSV-1 amplicon vectors |
| Q41964483 | Expression of human papillomavirus 6b L1 protein in silkworm larvae and enhanced green fluorescent protein displaying on its virus-like particles |
| Q36720912 | GARDASIL: prophylactic human papillomavirus vaccine development--from bench top to bed-side |
| Q44170300 | HPV antibody detection by ELISA with capsid protein L1 fused to glutathione S-transferase |
| Q35235035 | How will HPV vaccines affect cervical cancer? |
| Q38752656 | Human papillomavirus major capsid protein L1 remains associated with the incoming viral genome throughout the entry process |
| Q33785841 | Human papillomavirus type 11 recombinant L1 capsomeres induce virus-neutralizing antibodies |
| Q39742082 | Human papillomavirus type 16 L1 capsomeres induce L1-specific cytotoxic T lymphocytes and tumor regression in C57BL/6 mice |
| Q33908917 | Humoral immune response recognizes a complex set of epitopes on human papillomavirus type 6 l1 capsomers |
| Q33853398 | Immunization with a pentameric L1 fusion protein protects against papillomavirus infection |
| Q39723134 | In vitro gene transfer using human papillomavirus-like particles |
| Q47219010 | In vitro papillomavirus capsid assembly analyzed by light scattering |
| Q33782413 | Intercapsomeric disulfide bonds in papillomavirus assembly and disassembly. |
| Q37164879 | L2, the minor capsid protein of papillomavirus |
| Q34639978 | Multivalent human papillomavirus l1 DNA vaccination utilizing electroporation |
| Q43965189 | Oral vaccination of mice with human papillomavirus virus-like particles induces systemic virus-neutralizing antibodies. |
| Q38795804 | Papillomavirus assembly: An overview and perspectives |
| Q35193613 | Papillomavirus vaccines in clinical trials |
| Q34011494 | Perspectives for preventive and therapeutic HPV vaccines |
| Q36933885 | Possible role for cellular karyopherins in regulating polyomavirus and papillomavirus capsid assembly |
| Q45141835 | Production and purification of SV40 major capsid protein (VP1) in Escherichia coli strains deficient for the GroELS chaperone machine. |
| Q34315981 | Production of human papillomavirus type 16 L1 virus-like particles by recombinant Lactobacillus casei cells |
| Q39577044 | Quantitative disassembly and reassembly of human papillomavirus type 11 viruslike particles in vitro. |
| Q41859327 | Structure-based engineering of papillomavirus major capsid l1: controlling particle assembly |
| Q91688100 | Substitution of Human Papillomavirus Type 16 L2 Neutralizing Epitopes Into L1 Surface Loops: The Effect on Virus-Like Particle Assembly and Immunogenicity |
| Q27709061 | The C-Terminal Arm of the Human Papillomavirus Major Capsid Protein Is Immunogenic and Involved in Virus-Host Interaction |
| Q33673620 | The L1 major capsid protein of human papillomavirus type 16 variants affects yield of virus-like particles produced in an insect cell expression system |
| Q38603912 | The application of virus-like particles as vaccines and biological vehicles |
| Q30362003 | The human papillomavirus type 16 L1 protein directly interacts with E2 and enhances E2-dependent replication and transcription activation. |
| Q54080674 | Transplastomic expression of a modified human papillomavirus L1 protein leading to the assembly of capsomeres in tobacco: a step towards cost-effective second-generation vaccines. |
| Q35290961 | Viral assembly using heterologous expression systems and cell extracts |
Search more.